nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclophosphamide—CYP2A6—Pilocarpine—glaucoma	0.136	0.201	CbGbCtD
Cyclophosphamide—CYP2D6—Carteolol—glaucoma	0.0563	0.0834	CbGbCtD
Cyclophosphamide—CYP2D6—Betaxolol—glaucoma	0.038	0.0563	CbGbCtD
Cyclophosphamide—CYP2C19—Methazolamide—glaucoma	0.0379	0.0562	CbGbCtD
Cyclophosphamide—CYP2C9—Diclofenamide—glaucoma	0.0366	0.0542	CbGbCtD
Cyclophosphamide—CYP2C9—Dorzolamide—glaucoma	0.0354	0.0524	CbGbCtD
Cyclophosphamide—CYP3A5—Clonidine—glaucoma	0.034	0.0503	CbGbCtD
Cyclophosphamide—CYP2C19—Timolol—glaucoma	0.0323	0.0477	CbGbCtD
Cyclophosphamide—CYP2C9—Methazolamide—glaucoma	0.0315	0.0467	CbGbCtD
Cyclophosphamide—CYP2D6—Methazolamide—glaucoma	0.0288	0.0427	CbGbCtD
Cyclophosphamide—CYP3A4—Pilocarpine—glaucoma	0.0271	0.0402	CbGbCtD
Cyclophosphamide—ABCB1—Timolol—glaucoma	0.026	0.0385	CbGbCtD
Cyclophosphamide—CYP2D6—Timolol—glaucoma	0.0245	0.0363	CbGbCtD
Cyclophosphamide—ABCB1—Clonidine—glaucoma	0.0221	0.0328	CbGbCtD
Cyclophosphamide—CYP3A4—Brinzolamide—glaucoma	0.0213	0.0315	CbGbCtD
Cyclophosphamide—CYP2D6—Clonidine—glaucoma	0.0208	0.0309	CbGbCtD
Cyclophosphamide—CYP3A4—Dorzolamide—glaucoma	0.0206	0.0305	CbGbCtD
Cyclophosphamide—CYP3A4—Methazolamide—glaucoma	0.0183	0.0271	CbGbCtD
Cyclophosphamide—CYP3A4—Acetazolamide—glaucoma	0.0147	0.0217	CbGbCtD
Cyclophosphamide—CYP3A4—Clonidine—glaucoma	0.0133	0.0196	CbGbCtD
Cyclophosphamide—Rhinitis—Betaxolol—glaucoma	0.000208	0.000658	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Pilocarpine—glaucoma	0.000208	0.000657	CcSEcCtD
Cyclophosphamide—Erythema—Clonidine—glaucoma	0.000208	0.000656	CcSEcCtD
Cyclophosphamide—Tachycardia—Pilocarpine—glaucoma	0.000207	0.000655	CcSEcCtD
Cyclophosphamide—Hypoaesthesia—Betaxolol—glaucoma	0.000207	0.000653	CcSEcCtD
Cyclophosphamide—Hypotension—Brinzolamide—glaucoma	0.000206	0.000652	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Pilocarpine—glaucoma	0.000205	0.000648	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000205	0.000647	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Travoprost—glaucoma	0.000204	0.000644	CcSEcCtD
Cyclophosphamide—Fatigue—Brimonidine—glaucoma	0.000203	0.000641	CcSEcCtD
Cyclophosphamide—Anorexia—Pilocarpine—glaucoma	0.000202	0.000639	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Acetazolamide—glaucoma	0.000202	0.000638	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Apraclonidine—glaucoma	0.000202	0.000638	CcSEcCtD
Cyclophosphamide—Paraesthesia—Dorzolamide—glaucoma	0.000202	0.000637	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000201	0.000636	CcSEcCtD
Cyclophosphamide—Pain—Brimonidine—glaucoma	0.000201	0.000636	CcSEcCtD
Cyclophosphamide—Dyspnoea—Dorzolamide—glaucoma	0.0002	0.000633	CcSEcCtD
Cyclophosphamide—Visual impairment—Betaxolol—glaucoma	0.0002	0.000632	CcSEcCtD
Cyclophosphamide—Muscle spasms—Clonidine—glaucoma	0.0002	0.000631	CcSEcCtD
Cyclophosphamide—Dyspnoea—Travoprost—glaucoma	0.0002	0.00063	CcSEcCtD
Cyclophosphamide—Hypotension—Pilocarpine—glaucoma	0.000198	0.000627	CcSEcCtD
Cyclophosphamide—Paraesthesia—Brinzolamide—glaucoma	0.000198	0.000627	CcSEcCtD
Cyclophosphamide—Dyspnoea—Brinzolamide—glaucoma	0.000197	0.000622	CcSEcCtD
Cyclophosphamide—Asthenia—Apraclonidine—glaucoma	0.000197	0.000621	CcSEcCtD
Cyclophosphamide—Vision blurred—Clonidine—glaucoma	0.000196	0.000618	CcSEcCtD
Cyclophosphamide—Decreased appetite—Dorzolamide—glaucoma	0.000195	0.000617	CcSEcCtD
Cyclophosphamide—Urticaria—Acetazolamide—glaucoma	0.000195	0.000615	CcSEcCtD
Cyclophosphamide—Tremor—Clonidine—glaucoma	0.000195	0.000615	CcSEcCtD
Cyclophosphamide—Pruritus—Apraclonidine—glaucoma	0.000194	0.000612	CcSEcCtD
Cyclophosphamide—Body temperature increased—Acetazolamide—glaucoma	0.000194	0.000612	CcSEcCtD
Cyclophosphamide—Fatigue—Dorzolamide—glaucoma	0.000194	0.000612	CcSEcCtD
Cyclophosphamide—Tinnitus—Betaxolol—glaucoma	0.000194	0.000612	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000193	0.000611	CcSEcCtD
Cyclophosphamide—Fatigue—Travoprost—glaucoma	0.000193	0.000609	CcSEcCtD
Cyclophosphamide—Flushing—Betaxolol—glaucoma	0.000193	0.000609	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Clonidine—glaucoma	0.000193	0.000609	CcSEcCtD
Cyclophosphamide—Pain—Dorzolamide—glaucoma	0.000192	0.000607	CcSEcCtD
Cyclophosphamide—Decreased appetite—Brinzolamide—glaucoma	0.000192	0.000607	CcSEcCtD
Cyclophosphamide—Pain—Travoprost—glaucoma	0.000191	0.000604	CcSEcCtD
Cyclophosphamide—Constipation—Travoprost—glaucoma	0.000191	0.000604	CcSEcCtD
Cyclophosphamide—Hyperglycaemia—Timolol—glaucoma	0.000191	0.000604	CcSEcCtD
Cyclophosphamide—Agitation—Clonidine—glaucoma	0.000191	0.000603	CcSEcCtD
Cyclophosphamide—Paraesthesia—Pilocarpine—glaucoma	0.000191	0.000602	CcSEcCtD
Cyclophosphamide—Asthenia—Bimatoprost—glaucoma	0.000191	0.000602	CcSEcCtD
Cyclophosphamide—Fatigue—Brinzolamide—glaucoma	0.00019	0.000602	CcSEcCtD
Cyclophosphamide—Dyspnoea—Pilocarpine—glaucoma	0.000189	0.000598	CcSEcCtD
Cyclophosphamide—Pain—Brinzolamide—glaucoma	0.000189	0.000597	CcSEcCtD
Cyclophosphamide—Pruritus—Bimatoprost—glaucoma	0.000188	0.000594	CcSEcCtD
Cyclophosphamide—Diarrhoea—Apraclonidine—glaucoma	0.000188	0.000592	CcSEcCtD
Cyclophosphamide—Malaise—Clonidine—glaucoma	0.000187	0.000592	CcSEcCtD
Cyclophosphamide—Chills—Betaxolol—glaucoma	0.000186	0.000589	CcSEcCtD
Cyclophosphamide—Arrhythmia—Betaxolol—glaucoma	0.000186	0.000586	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Dorzolamide—glaucoma	0.000185	0.000585	CcSEcCtD
Cyclophosphamide—Decreased appetite—Pilocarpine—glaucoma	0.000185	0.000583	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Travoprost—glaucoma	0.000184	0.000582	CcSEcCtD
Cyclophosphamide—Conjunctivitis—Timolol—glaucoma	0.000184	0.000581	CcSEcCtD
Cyclophosphamide—Alopecia—Betaxolol—glaucoma	0.000184	0.00058	CcSEcCtD
Cyclophosphamide—Palpitations—Clonidine—glaucoma	0.000184	0.00058	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Brinzolamide—glaucoma	0.000182	0.000575	CcSEcCtD
Cyclophosphamide—Pain—Pilocarpine—glaucoma	0.000182	0.000573	CcSEcCtD
Cyclophosphamide—Constipation—Pilocarpine—glaucoma	0.000182	0.000573	CcSEcCtD
Cyclophosphamide—Cough—Clonidine—glaucoma	0.000181	0.000573	CcSEcCtD
Cyclophosphamide—Sweating—Timolol—glaucoma	0.000181	0.000573	CcSEcCtD
Cyclophosphamide—Dizziness—Apraclonidine—glaucoma	0.000181	0.000572	CcSEcCtD
Cyclophosphamide—Erythema—Betaxolol—glaucoma	0.000181	0.000571	CcSEcCtD
Cyclophosphamide—Urticaria—Dorzolamide—glaucoma	0.000179	0.000564	CcSEcCtD
Cyclophosphamide—Body temperature increased—Dorzolamide—glaucoma	0.000178	0.000561	CcSEcCtD
Cyclophosphamide—Dysgeusia—Betaxolol—glaucoma	0.000177	0.000559	CcSEcCtD
Cyclophosphamide—Arthralgia—Clonidine—glaucoma	0.000177	0.000559	CcSEcCtD
Cyclophosphamide—Chest pain—Clonidine—glaucoma	0.000177	0.000559	CcSEcCtD
Cyclophosphamide—Agranulocytosis—Timolol—glaucoma	0.000176	0.000557	CcSEcCtD
Cyclophosphamide—Asthenia—Acetazolamide—glaucoma	0.000176	0.000556	CcSEcCtD
Cyclophosphamide—Dizziness—Bimatoprost—glaucoma	0.000176	0.000555	CcSEcCtD
Cyclophosphamide—Urticaria—Brinzolamide—glaucoma	0.000176	0.000554	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Pilocarpine—glaucoma	0.000175	0.000553	CcSEcCtD
Cyclophosphamide—Discomfort—Clonidine—glaucoma	0.000175	0.000552	CcSEcCtD
Cyclophosphamide—Vomiting—Apraclonidine—glaucoma	0.000174	0.00055	CcSEcCtD
Cyclophosphamide—Muscle spasms—Betaxolol—glaucoma	0.000174	0.000549	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Brimonidine—glaucoma	0.000173	0.000548	CcSEcCtD
Cyclophosphamide—Bradycardia—Timolol—glaucoma	0.000173	0.000546	CcSEcCtD
Cyclophosphamide—Dermatitis—Apraclonidine—glaucoma	0.000173	0.000545	CcSEcCtD
Cyclophosphamide—Headache—Apraclonidine—glaucoma	0.000172	0.000542	CcSEcCtD
Cyclophosphamide—Confusional state—Clonidine—glaucoma	0.000171	0.00054	CcSEcCtD
Cyclophosphamide—Vision blurred—Betaxolol—glaucoma	0.00017	0.000538	CcSEcCtD
Cyclophosphamide—Rhinitis—Timolol—glaucoma	0.00017	0.000538	CcSEcCtD
Cyclophosphamide—Oedema—Clonidine—glaucoma	0.00017	0.000536	CcSEcCtD
Cyclophosphamide—Tremor—Betaxolol—glaucoma	0.000169	0.000535	CcSEcCtD
Cyclophosphamide—Asthenia—Brimonidine—glaucoma	0.000169	0.000533	CcSEcCtD
Cyclophosphamide—Infection—Clonidine—glaucoma	0.000168	0.000532	CcSEcCtD
Cyclophosphamide—Body temperature increased—Pilocarpine—glaucoma	0.000168	0.00053	CcSEcCtD
Cyclophosphamide—Ill-defined disorder—Betaxolol—glaucoma	0.000168	0.00053	CcSEcCtD
Cyclophosphamide—Diarrhoea—Acetazolamide—glaucoma	0.000168	0.00053	CcSEcCtD
Cyclophosphamide—Rash—Bimatoprost—glaucoma	0.000168	0.000529	CcSEcCtD
Cyclophosphamide—Dermatitis—Bimatoprost—glaucoma	0.000167	0.000529	CcSEcCtD
Cyclophosphamide—Anaemia—Betaxolol—glaucoma	0.000167	0.000528	CcSEcCtD
Cyclophosphamide—Shock—Clonidine—glaucoma	0.000167	0.000527	CcSEcCtD
Cyclophosphamide—Pruritus—Brimonidine—glaucoma	0.000166	0.000526	CcSEcCtD
Cyclophosphamide—Headache—Bimatoprost—glaucoma	0.000166	0.000526	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Clonidine—glaucoma	0.000166	0.000524	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Dorzolamide—glaucoma	0.000166	0.000523	CcSEcCtD
Cyclophosphamide—Tachycardia—Clonidine—glaucoma	0.000166	0.000523	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Travoprost—glaucoma	0.000165	0.000521	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Clonidine—glaucoma	0.000164	0.000518	CcSEcCtD
Cyclophosphamide—Visual impairment—Timolol—glaucoma	0.000164	0.000517	CcSEcCtD
Cyclophosphamide—Malaise—Betaxolol—glaucoma	0.000163	0.000515	CcSEcCtD
Cyclophosphamide—Nausea—Apraclonidine—glaucoma	0.000163	0.000514	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Brinzolamide—glaucoma	0.000163	0.000514	CcSEcCtD
Cyclophosphamide—Dizziness—Acetazolamide—glaucoma	0.000162	0.000512	CcSEcCtD
Cyclophosphamide—Anorexia—Clonidine—glaucoma	0.000162	0.000511	CcSEcCtD
Cyclophosphamide—Asthenia—Dorzolamide—glaucoma	0.000161	0.000509	CcSEcCtD
Cyclophosphamide—Asthenia—Travoprost—glaucoma	0.000161	0.000507	CcSEcCtD
Cyclophosphamide—Palpitations—Betaxolol—glaucoma	0.00016	0.000505	CcSEcCtD
Cyclophosphamide—Pruritus—Dorzolamide—glaucoma	0.000159	0.000502	CcSEcCtD
Cyclophosphamide—Asthenia—Brinzolamide—glaucoma	0.000159	0.000501	CcSEcCtD
Cyclophosphamide—Hypotension—Clonidine—glaucoma	0.000158	0.0005	CcSEcCtD
Cyclophosphamide—Pruritus—Travoprost—glaucoma	0.000158	0.0005	CcSEcCtD
Cyclophosphamide—Tinnitus—Timolol—glaucoma	0.000158	0.0005	CcSEcCtD
Cyclophosphamide—Cough—Betaxolol—glaucoma	0.000158	0.000499	CcSEcCtD
Cyclophosphamide—Nausea—Bimatoprost—glaucoma	0.000158	0.000499	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Pilocarpine—glaucoma	0.000156	0.000494	CcSEcCtD
Cyclophosphamide—Pruritus—Brinzolamide—glaucoma	0.000156	0.000494	CcSEcCtD
Cyclophosphamide—Vomiting—Acetazolamide—glaucoma	0.000156	0.000492	CcSEcCtD
Cyclophosphamide—Dizziness—Brimonidine—glaucoma	0.000156	0.000491	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Clonidine—glaucoma	0.000155	0.000488	CcSEcCtD
Cyclophosphamide—Arthralgia—Betaxolol—glaucoma	0.000154	0.000486	CcSEcCtD
Cyclophosphamide—Chest pain—Betaxolol—glaucoma	0.000154	0.000486	CcSEcCtD
Cyclophosphamide—Myalgia—Betaxolol—glaucoma	0.000154	0.000486	CcSEcCtD
Cyclophosphamide—Diarrhoea—Dorzolamide—glaucoma	0.000154	0.000486	CcSEcCtD
Cyclophosphamide—Headache—Acetazolamide—glaucoma	0.000154	0.000485	CcSEcCtD
Cyclophosphamide—Diarrhoea—Travoprost—glaucoma	0.000153	0.000484	CcSEcCtD
Cyclophosphamide—Asthenia—Pilocarpine—glaucoma	0.000152	0.000481	CcSEcCtD
Cyclophosphamide—Paraesthesia—Clonidine—glaucoma	0.000152	0.000481	CcSEcCtD
Cyclophosphamide—Discomfort—Betaxolol—glaucoma	0.000152	0.000481	CcSEcCtD
Cyclophosphamide—Arrhythmia—Timolol—glaucoma	0.000152	0.000479	CcSEcCtD
Cyclophosphamide—Dyspnoea—Clonidine—glaucoma	0.000151	0.000477	CcSEcCtD
Cyclophosphamide—Diarrhoea—Brinzolamide—glaucoma	0.000151	0.000477	CcSEcCtD
Cyclophosphamide—Pruritus—Pilocarpine—glaucoma	0.00015	0.000474	CcSEcCtD
Cyclophosphamide—Alopecia—Timolol—glaucoma	0.00015	0.000474	CcSEcCtD
Cyclophosphamide—Confusional state—Betaxolol—glaucoma	0.000149	0.00047	CcSEcCtD
Cyclophosphamide—Dizziness—Dorzolamide—glaucoma	0.000149	0.000469	CcSEcCtD
Cyclophosphamide—Rash—Brimonidine—glaucoma	0.000148	0.000469	CcSEcCtD
Cyclophosphamide—Dermatitis—Brimonidine—glaucoma	0.000148	0.000468	CcSEcCtD
Cyclophosphamide—Dizziness—Travoprost—glaucoma	0.000148	0.000467	CcSEcCtD
Cyclophosphamide—Erythema—Timolol—glaucoma	0.000148	0.000467	CcSEcCtD
Cyclophosphamide—Oedema—Betaxolol—glaucoma	0.000148	0.000466	CcSEcCtD
Cyclophosphamide—Headache—Brimonidine—glaucoma	0.000147	0.000466	CcSEcCtD
Cyclophosphamide—Decreased appetite—Clonidine—glaucoma	0.000147	0.000466	CcSEcCtD
Cyclophosphamide—Infection—Betaxolol—glaucoma	0.000147	0.000463	CcSEcCtD
Cyclophosphamide—Fatigue—Clonidine—glaucoma	0.000146	0.000462	CcSEcCtD
Cyclophosphamide—Dizziness—Brinzolamide—glaucoma	0.000146	0.000461	CcSEcCtD
Cyclophosphamide—Nausea—Acetazolamide—glaucoma	0.000146	0.00046	CcSEcCtD
Cyclophosphamide—Diarrhoea—Pilocarpine—glaucoma	0.000145	0.000459	CcSEcCtD
Cyclophosphamide—Shock—Betaxolol—glaucoma	0.000145	0.000459	CcSEcCtD
Cyclophosphamide—Constipation—Clonidine—glaucoma	0.000145	0.000458	CcSEcCtD
Cyclophosphamide—Pain—Clonidine—glaucoma	0.000145	0.000458	CcSEcCtD
Cyclophosphamide—Dysgeusia—Timolol—glaucoma	0.000145	0.000457	CcSEcCtD
Cyclophosphamide—Thrombocytopenia—Betaxolol—glaucoma	0.000145	0.000457	CcSEcCtD
Cyclophosphamide—Tachycardia—Betaxolol—glaucoma	0.000144	0.000455	CcSEcCtD
Cyclophosphamide—Vomiting—Dorzolamide—glaucoma	0.000143	0.000451	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Betaxolol—glaucoma	0.000143	0.000451	CcSEcCtD
Cyclophosphamide—Rash—Dorzolamide—glaucoma	0.000142	0.000448	CcSEcCtD
Cyclophosphamide—Dermatitis—Dorzolamide—glaucoma	0.000142	0.000447	CcSEcCtD
Cyclophosphamide—Rash—Travoprost—glaucoma	0.000141	0.000446	CcSEcCtD
Cyclophosphamide—Dermatitis—Travoprost—glaucoma	0.000141	0.000445	CcSEcCtD
Cyclophosphamide—Headache—Dorzolamide—glaucoma	0.000141	0.000445	CcSEcCtD
Cyclophosphamide—Anorexia—Betaxolol—glaucoma	0.000141	0.000444	CcSEcCtD
Cyclophosphamide—Vomiting—Brinzolamide—glaucoma	0.00014	0.000444	CcSEcCtD
Cyclophosphamide—Dizziness—Pilocarpine—glaucoma	0.00014	0.000443	CcSEcCtD
Cyclophosphamide—Headache—Travoprost—glaucoma	0.00014	0.000443	CcSEcCtD
Cyclophosphamide—Nausea—Brimonidine—glaucoma	0.00014	0.000441	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Clonidine—glaucoma	0.00014	0.000441	CcSEcCtD
Cyclophosphamide—Rash—Brinzolamide—glaucoma	0.000139	0.00044	CcSEcCtD
Cyclophosphamide—Vision blurred—Timolol—glaucoma	0.000139	0.00044	CcSEcCtD
Cyclophosphamide—Dermatitis—Brinzolamide—glaucoma	0.000139	0.00044	CcSEcCtD
Cyclophosphamide—Headache—Brinzolamide—glaucoma	0.000138	0.000437	CcSEcCtD
Cyclophosphamide—Hypotension—Betaxolol—glaucoma	0.000138	0.000436	CcSEcCtD
Cyclophosphamide—Vomiting—Pilocarpine—glaucoma	0.000135	0.000426	CcSEcCtD
Cyclophosphamide—Urticaria—Clonidine—glaucoma	0.000135	0.000425	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000135	0.000425	CcSEcCtD
Cyclophosphamide—Body temperature increased—Clonidine—glaucoma	0.000134	0.000423	CcSEcCtD
Cyclophosphamide—Rash—Pilocarpine—glaucoma	0.000134	0.000423	CcSEcCtD
Cyclophosphamide—Dermatitis—Pilocarpine—glaucoma	0.000134	0.000422	CcSEcCtD
Cyclophosphamide—Nausea—Dorzolamide—glaucoma	0.000133	0.000422	CcSEcCtD
Cyclophosphamide—Headache—Pilocarpine—glaucoma	0.000133	0.00042	CcSEcCtD
Cyclophosphamide—Nausea—Travoprost—glaucoma	0.000133	0.00042	CcSEcCtD
Cyclophosphamide—Paraesthesia—Betaxolol—glaucoma	0.000133	0.000419	CcSEcCtD
Cyclophosphamide—Dyspnoea—Betaxolol—glaucoma	0.000132	0.000416	CcSEcCtD
Cyclophosphamide—Nausea—Brinzolamide—glaucoma	0.000131	0.000414	CcSEcCtD
Cyclophosphamide—Palpitations—Timolol—glaucoma	0.000131	0.000412	CcSEcCtD
Cyclophosphamide—Cough—Timolol—glaucoma	0.000129	0.000407	CcSEcCtD
Cyclophosphamide—Decreased appetite—Betaxolol—glaucoma	0.000128	0.000405	CcSEcCtD
Cyclophosphamide—Hypertension—Timolol—glaucoma	0.000128	0.000403	CcSEcCtD
Cyclophosphamide—Fatigue—Betaxolol—glaucoma	0.000127	0.000402	CcSEcCtD
Cyclophosphamide—Constipation—Betaxolol—glaucoma	0.000126	0.000399	CcSEcCtD
Cyclophosphamide—Pain—Betaxolol—glaucoma	0.000126	0.000399	CcSEcCtD
Cyclophosphamide—Nausea—Pilocarpine—glaucoma	0.000126	0.000398	CcSEcCtD
Cyclophosphamide—Chest pain—Timolol—glaucoma	0.000126	0.000397	CcSEcCtD
Cyclophosphamide—Arthralgia—Timolol—glaucoma	0.000126	0.000397	CcSEcCtD
Cyclophosphamide—Myalgia—Timolol—glaucoma	0.000126	0.000397	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Clonidine—glaucoma	0.000125	0.000395	CcSEcCtD
Cyclophosphamide—Discomfort—Timolol—glaucoma	0.000124	0.000393	CcSEcCtD
Cyclophosphamide—Asthenia—Clonidine—glaucoma	0.000122	0.000384	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Betaxolol—glaucoma	0.000122	0.000384	CcSEcCtD
Cyclophosphamide—Confusional state—Timolol—glaucoma	0.000122	0.000384	CcSEcCtD
Cyclophosphamide—Anaphylactic shock—Timolol—glaucoma	0.000121	0.000381	CcSEcCtD
Cyclophosphamide—Oedema—Timolol—glaucoma	0.000121	0.000381	CcSEcCtD
Cyclophosphamide—Pruritus—Clonidine—glaucoma	0.00012	0.000379	CcSEcCtD
Cyclophosphamide—Infection—Timolol—glaucoma	0.00012	0.000378	CcSEcCtD
Cyclophosphamide—Shock—Timolol—glaucoma	0.000119	0.000375	CcSEcCtD
Cyclophosphamide—Urticaria—Betaxolol—glaucoma	0.000117	0.00037	CcSEcCtD
Cyclophosphamide—Body temperature increased—Betaxolol—glaucoma	0.000117	0.000369	CcSEcCtD
Cyclophosphamide—Hyperhidrosis—Timolol—glaucoma	0.000117	0.000368	CcSEcCtD
Cyclophosphamide—Diarrhoea—Clonidine—glaucoma	0.000116	0.000366	CcSEcCtD
Cyclophosphamide—Anorexia—Timolol—glaucoma	0.000115	0.000363	CcSEcCtD
Cyclophosphamide—Hypotension—Timolol—glaucoma	0.000113	0.000356	CcSEcCtD
Cyclophosphamide—Dizziness—Clonidine—glaucoma	0.000112	0.000354	CcSEcCtD
Cyclophosphamide—Musculoskeletal discomfort—Timolol—glaucoma	0.00011	0.000347	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Betaxolol—glaucoma	0.000109	0.000344	CcSEcCtD
Cyclophosphamide—Paraesthesia—Timolol—glaucoma	0.000108	0.000342	CcSEcCtD
Cyclophosphamide—Vomiting—Clonidine—glaucoma	0.000108	0.000341	CcSEcCtD
Cyclophosphamide—Dyspnoea—Timolol—glaucoma	0.000108	0.00034	CcSEcCtD
Cyclophosphamide—Rash—Clonidine—glaucoma	0.000107	0.000338	CcSEcCtD
Cyclophosphamide—Dermatitis—Clonidine—glaucoma	0.000107	0.000337	CcSEcCtD
Cyclophosphamide—Headache—Clonidine—glaucoma	0.000106	0.000336	CcSEcCtD
Cyclophosphamide—Asthenia—Betaxolol—glaucoma	0.000106	0.000335	CcSEcCtD
Cyclophosphamide—Decreased appetite—Timolol—glaucoma	0.000105	0.000331	CcSEcCtD
Cyclophosphamide—Pruritus—Betaxolol—glaucoma	0.000104	0.00033	CcSEcCtD
Cyclophosphamide—Fatigue—Timolol—glaucoma	0.000104	0.000328	CcSEcCtD
Cyclophosphamide—Pain—Timolol—glaucoma	0.000103	0.000326	CcSEcCtD
Cyclophosphamide—Diarrhoea—Betaxolol—glaucoma	0.000101	0.000319	CcSEcCtD
Cyclophosphamide—Nausea—Clonidine—glaucoma	0.000101	0.000318	CcSEcCtD
Cyclophosphamide—Feeling abnormal—Timolol—glaucoma	9.94e-05	0.000314	CcSEcCtD
Cyclophosphamide—Dizziness—Betaxolol—glaucoma	9.76e-05	0.000308	CcSEcCtD
Cyclophosphamide—Urticaria—Timolol—glaucoma	9.58e-05	0.000303	CcSEcCtD
Cyclophosphamide—Body temperature increased—Timolol—glaucoma	9.53e-05	0.000301	CcSEcCtD
Cyclophosphamide—Vomiting—Betaxolol—glaucoma	9.39e-05	0.000296	CcSEcCtD
Cyclophosphamide—Rash—Betaxolol—glaucoma	9.31e-05	0.000294	CcSEcCtD
Cyclophosphamide—Dermatitis—Betaxolol—glaucoma	9.3e-05	0.000294	CcSEcCtD
Cyclophosphamide—Headache—Betaxolol—glaucoma	9.25e-05	0.000292	CcSEcCtD
Cyclophosphamide—Hypersensitivity—Timolol—glaucoma	8.89e-05	0.000281	CcSEcCtD
Cyclophosphamide—Nausea—Betaxolol—glaucoma	8.77e-05	0.000277	CcSEcCtD
Cyclophosphamide—Asthenia—Timolol—glaucoma	8.65e-05	0.000273	CcSEcCtD
Cyclophosphamide—Pruritus—Timolol—glaucoma	8.53e-05	0.000269	CcSEcCtD
Cyclophosphamide—Diarrhoea—Timolol—glaucoma	8.25e-05	0.000261	CcSEcCtD
Cyclophosphamide—Dizziness—Timolol—glaucoma	7.98e-05	0.000252	CcSEcCtD
Cyclophosphamide—Vomiting—Timolol—glaucoma	7.67e-05	0.000242	CcSEcCtD
Cyclophosphamide—Rash—Timolol—glaucoma	7.61e-05	0.00024	CcSEcCtD
Cyclophosphamide—Dermatitis—Timolol—glaucoma	7.6e-05	0.00024	CcSEcCtD
Cyclophosphamide—Headache—Timolol—glaucoma	7.56e-05	0.000239	CcSEcCtD
Cyclophosphamide—Nausea—Timolol—glaucoma	7.16e-05	0.000226	CcSEcCtD
Cyclophosphamide—CYP2B6—Biological oxidations—GSTT1—glaucoma	2.71e-05	0.00343	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Fluoropyrimidine Activity—TP53—glaucoma	2.69e-05	0.00341	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Biological oxidations—CYP1B1—glaucoma	2.68e-05	0.00339	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—GSTT1—glaucoma	2.65e-05	0.00335	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CA5A—glaucoma	2.57e-05	0.00325	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NARFL—glaucoma	2.57e-05	0.00325	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	2.55e-05	0.00322	CbGpPWpGaD
Cyclophosphamide—CYP2A6—NRF2 pathway—GSTM1—glaucoma	2.44e-05	0.00309	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—IL1A—glaucoma	2.39e-05	0.00302	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CA5A—glaucoma	2.36e-05	0.00298	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NARFL—glaucoma	2.36e-05	0.00298	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Biological oxidations—GSTM1—glaucoma	2.34e-05	0.00296	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metapathway biotransformation—GSTM1—glaucoma	2.31e-05	0.00291	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—GSTT1—glaucoma	2.3e-05	0.00291	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	2.28e-05	0.00289	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	2.25e-05	0.00285	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	2.22e-05	0.0028	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—CYP1B1—glaucoma	2.16e-05	0.00273	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Biological oxidations—GSTM1—glaucoma	2.14e-05	0.00271	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—CYP1B1—glaucoma	2.13e-05	0.0027	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—FAS—glaucoma	2.13e-05	0.00269	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—CYP1B1—glaucoma	2.11e-05	0.00267	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—C3—glaucoma	2.1e-05	0.00265	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—CYP1B1—glaucoma	2.09e-05	0.00264	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTT1—glaucoma	2.05e-05	0.00259	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	1.98e-05	0.0025	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CA5A—glaucoma	1.9e-05	0.0024	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NARFL—glaucoma	1.9e-05	0.0024	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CA1—glaucoma	1.89e-05	0.00239	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTT1—glaucoma	1.89e-05	0.00238	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTT1—glaucoma	1.87e-05	0.00236	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CA5A—glaucoma	1.86e-05	0.00235	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NARFL—glaucoma	1.86e-05	0.00235	CbGpPWpGaD
Cyclophosphamide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	1.86e-05	0.00235	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	1.85e-05	0.00234	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—CYP1B1—glaucoma	1.83e-05	0.00231	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CTSA—glaucoma	1.83e-05	0.00231	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	1.81e-05	0.00228	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	1.8e-05	0.00228	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	1.8e-05	0.00227	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Biological oxidations—GSTM1—glaucoma	1.73e-05	0.00219	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CA2—glaucoma	1.73e-05	0.00218	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	1.72e-05	0.00218	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.71e-05	0.00216	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metapathway biotransformation—GSTM1—glaucoma	1.71e-05	0.00216	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Biological oxidations—GSTM1—glaucoma	1.69e-05	0.00214	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metapathway biotransformation—GSTM1—glaucoma	1.67e-05	0.00211	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—CYP1B1—glaucoma	1.63e-05	0.00207	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	1.61e-05	0.00204	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NARFL—glaucoma	1.61e-05	0.00204	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CA5A—glaucoma	1.61e-05	0.00204	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.53e-05	0.00193	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—CYP1B1—glaucoma	1.5e-05	0.0019	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—CYP1B1—glaucoma	1.49e-05	0.00188	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	1.48e-05	0.00187	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	1.47e-05	0.00186	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Biological oxidations—GSTM1—glaucoma	1.46e-05	0.00185	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	1.44e-05	0.00182	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NARFL—glaucoma	1.44e-05	0.00182	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CA5A—glaucoma	1.44e-05	0.00182	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CA5A—glaucoma	1.4e-05	0.00177	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NARFL—glaucoma	1.4e-05	0.00177	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	1.39e-05	0.00176	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	1.34e-05	0.0017	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CA5A—glaucoma	1.32e-05	0.00167	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NARFL—glaucoma	1.32e-05	0.00167	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NARFL—glaucoma	1.31e-05	0.00166	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CA5A—glaucoma	1.31e-05	0.00166	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Biological oxidations—GSTM1—glaucoma	1.31e-05	0.00165	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	1.29e-05	0.00163	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CA1—glaucoma	1.26e-05	0.00159	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	1.24e-05	0.00156	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTT1—glaucoma	1.23e-05	0.00156	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	1.23e-05	0.00155	CbGpPWpGaD
Cyclophosphamide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	1.22e-05	0.00154	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—TXN—glaucoma	1.22e-05	0.00154	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CTSA—glaucoma	1.22e-05	0.00154	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Biological oxidations—GSTM1—glaucoma	1.2e-05	0.00152	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Biological oxidations—GSTM1—glaucoma	1.19e-05	0.00151	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	1.19e-05	0.0015	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	1.18e-05	0.00149	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CA1—glaucoma	1.15e-05	0.00146	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CA2—glaucoma	1.15e-05	0.00145	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	1.15e-05	0.00145	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CTSA—glaucoma	1.12e-05	0.00141	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—VEGFA—glaucoma	1.06e-05	0.00133	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CA2—glaucoma	1.05e-05	0.00133	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	1.05e-05	0.00133	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.83e-06	0.00124	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.69e-06	0.00123	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTT1—glaucoma	9.44e-06	0.00119	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CA1—glaucoma	9.29e-06	0.00117	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CA1—glaucoma	9.08e-06	0.00115	CbGpPWpGaD
Cyclophosphamide—ABCB1—Allograft Rejection—TNF—glaucoma	9.05e-06	0.00114	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CTSA—glaucoma	9e-06	0.00114	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	8.99e-06	0.00114	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CTSA—glaucoma	8.8e-06	0.00111	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NARFL—glaucoma	8.65e-06	0.00109	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA5A—glaucoma	8.65e-06	0.00109	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CA2—glaucoma	8.5e-06	0.00107	CbGpPWpGaD
Cyclophosphamide—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	8.4e-06	0.00106	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CA2—glaucoma	8.31e-06	0.00105	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—TXN—glaucoma	8.1e-06	0.00102	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CA1—glaucoma	7.87e-06	0.000994	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.86e-06	0.000993	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.75e-06	0.00098	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CTSA—glaucoma	7.62e-06	0.000963	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CYP1B1—glaucoma	7.52e-06	0.000951	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—ABCA1—glaucoma	7.52e-06	0.000951	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—TXN—glaucoma	7.42e-06	0.000938	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CA2—glaucoma	7.2e-06	0.000909	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	7.03e-06	0.000889	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	7.03e-06	0.000889	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CA1—glaucoma	7.02e-06	0.000887	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CA1—glaucoma	6.85e-06	0.000866	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CTSA—glaucoma	6.8e-06	0.00086	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CTSA—glaucoma	6.64e-06	0.000839	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	6.61e-06	0.000836	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CA1—glaucoma	6.46e-06	0.000816	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CA2—glaucoma	6.42e-06	0.000812	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CA1—glaucoma	6.4e-06	0.000809	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTT1—glaucoma	6.28e-06	0.000793	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.28e-06	0.000793	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.28e-06	0.000793	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CA2—glaucoma	6.27e-06	0.000792	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	6.26e-06	0.000792	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CTSA—glaucoma	6.25e-06	0.000791	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CTSA—glaucoma	6.2e-06	0.000784	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—GSTM1—glaucoma	6.02e-06	0.00076	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—TXN—glaucoma	5.99e-06	0.000757	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CA2—glaucoma	5.91e-06	0.000747	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CA2—glaucoma	5.86e-06	0.00074	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—TXN—glaucoma	5.85e-06	0.00074	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTT1—glaucoma	5.75e-06	0.000727	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	5.72e-06	0.000723	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	5.72e-06	0.000723	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—MTHFR—glaucoma	5.32e-06	0.000672	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	5.21e-06	0.000658	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—TXN—glaucoma	5.07e-06	0.000641	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CYP1B1—glaucoma	5e-06	0.000632	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—ABCA1—glaucoma	5e-06	0.000632	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—APOE—glaucoma	4.95e-06	0.000626	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—CAV1—glaucoma	4.9e-06	0.00062	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTT1—glaucoma	4.64e-06	0.000587	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.63e-06	0.000585	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—ABCA1—glaucoma	4.58e-06	0.000579	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CYP1B1—glaucoma	4.58e-06	0.000579	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.58e-06	0.000579	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTT1—glaucoma	4.54e-06	0.000574	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—TXN—glaucoma	4.52e-06	0.000572	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	4.46e-06	0.000564	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—TXN—glaucoma	4.42e-06	0.000558	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA1—glaucoma	4.22e-06	0.000534	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—TXN—glaucoma	4.16e-06	0.000526	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.13e-06	0.000522	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—TXN—glaucoma	4.13e-06	0.000521	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.09e-06	0.000517	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CTSA—glaucoma	4.09e-06	0.000517	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—GSTM1—glaucoma	4e-06	0.000505	CbGpPWpGaD
Cyclophosphamide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	3.94e-06	0.000497	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTT1—glaucoma	3.93e-06	0.000497	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CA2—glaucoma	3.86e-06	0.000488	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.76e-06	0.000476	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.73e-06	0.000471	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—NOS3—glaucoma	3.71e-06	0.000469	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—ABCA1—glaucoma	3.7e-06	0.000468	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CYP1B1—glaucoma	3.7e-06	0.000468	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—GSTM1—glaucoma	3.67e-06	0.000463	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—ABCA1—glaucoma	3.62e-06	0.000457	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CYP1B1—glaucoma	3.62e-06	0.000457	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—MTHFR—glaucoma	3.53e-06	0.000447	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTT1—glaucoma	3.51e-06	0.000443	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTT1—glaucoma	3.42e-06	0.000433	CbGpPWpGaD
Cyclophosphamide—CYP2C18—Metabolism—PTGS2—glaucoma	3.39e-06	0.000429	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—APOE—glaucoma	3.29e-06	0.000416	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—CAV1—glaucoma	3.26e-06	0.000412	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—MTHFR—glaucoma	3.24e-06	0.000409	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTT1—glaucoma	3.23e-06	0.000408	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTT1—glaucoma	3.2e-06	0.000404	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	3.17e-06	0.000401	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CYP1B1—glaucoma	3.13e-06	0.000396	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—ABCA1—glaucoma	3.13e-06	0.000396	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—APOE—glaucoma	3.02e-06	0.000381	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—CAV1—glaucoma	2.99e-06	0.000378	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—GSTM1—glaucoma	2.96e-06	0.000374	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—GSTM1—glaucoma	2.89e-06	0.000365	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.83e-06	0.000358	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CYP1B1—glaucoma	2.8e-06	0.000353	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—ABCA1—glaucoma	2.8e-06	0.000353	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CYP1B1—glaucoma	2.73e-06	0.000345	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—ABCA1—glaucoma	2.73e-06	0.000345	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—TXN—glaucoma	2.72e-06	0.000344	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—MTHFR—glaucoma	2.61e-06	0.00033	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.58e-06	0.000326	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CYP1B1—glaucoma	2.57e-06	0.000325	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—ABCA1—glaucoma	2.57e-06	0.000325	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—MTHFR—glaucoma	2.55e-06	0.000323	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—ABCA1—glaucoma	2.55e-06	0.000322	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CYP1B1—glaucoma	2.55e-06	0.000322	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—GSTM1—glaucoma	2.5e-06	0.000316	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—NOS3—glaucoma	2.46e-06	0.000312	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—APOE—glaucoma	2.43e-06	0.000308	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—CAV1—glaucoma	2.41e-06	0.000305	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—APOE—glaucoma	2.38e-06	0.000301	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—CAV1—glaucoma	2.36e-06	0.000298	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—NOS3—glaucoma	2.26e-06	0.000286	CbGpPWpGaD
Cyclophosphamide—CYP3A7—Metabolism—PTGS2—glaucoma	2.25e-06	0.000285	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—GSTM1—glaucoma	2.23e-06	0.000282	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—MTHFR—glaucoma	2.21e-06	0.00028	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—GSTM1—glaucoma	2.18e-06	0.000276	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTT1—glaucoma	2.11e-06	0.000267	CbGpPWpGaD
Cyclophosphamide—CYP2A6—Metabolism—PTGS2—glaucoma	2.07e-06	0.000261	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—APOE—glaucoma	2.06e-06	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—GSTM1—glaucoma	2.06e-06	0.00026	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—CAV1—glaucoma	2.04e-06	0.000258	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—GSTM1—glaucoma	2.04e-06	0.000258	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—MTHFR—glaucoma	1.98e-06	0.00025	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—MTHFR—glaucoma	1.93e-06	0.000244	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—APOE—glaucoma	1.84e-06	0.000232	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—NOS3—glaucoma	1.82e-06	0.00023	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—CAV1—glaucoma	1.82e-06	0.00023	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—MTHFR—glaucoma	1.82e-06	0.00023	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—MTHFR—glaucoma	1.8e-06	0.000228	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—APOE—glaucoma	1.79e-06	0.000227	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—NOS3—glaucoma	1.78e-06	0.000225	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—CAV1—glaucoma	1.78e-06	0.000225	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—APOE—glaucoma	1.69e-06	0.000214	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—ABCA1—glaucoma	1.68e-06	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CYP1B1—glaucoma	1.68e-06	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—APOE—glaucoma	1.68e-06	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—CAV1—glaucoma	1.68e-06	0.000212	CbGpPWpGaD
Cyclophosphamide—CYP2B6—Metabolism—PTGS2—glaucoma	1.67e-06	0.000211	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—CAV1—glaucoma	1.66e-06	0.00021	CbGpPWpGaD
Cyclophosphamide—CYP3A5—Metabolism—PTGS2—glaucoma	1.63e-06	0.000206	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—NOS3—glaucoma	1.54e-06	0.000195	CbGpPWpGaD
Cyclophosphamide—CYP2C8—Metabolism—PTGS2—glaucoma	1.41e-06	0.000178	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—NOS3—glaucoma	1.38e-06	0.000174	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—NOS3—glaucoma	1.34e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—GSTM1—glaucoma	1.34e-06	0.00017	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—NOS3—glaucoma	1.27e-06	0.00016	CbGpPWpGaD
Cyclophosphamide—CYP2C19—Metabolism—PTGS2—glaucoma	1.26e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—NOS3—glaucoma	1.26e-06	0.000159	CbGpPWpGaD
Cyclophosphamide—ABCB1—Metabolism—PTGS2—glaucoma	1.23e-06	0.000155	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—MTHFR—glaucoma	1.19e-06	0.00015	CbGpPWpGaD
Cyclophosphamide—CYP2D6—Metabolism—PTGS2—glaucoma	1.16e-06	0.000146	CbGpPWpGaD
Cyclophosphamide—CYP2C9—Metabolism—PTGS2—glaucoma	1.15e-06	0.000145	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—APOE—glaucoma	1.11e-06	0.00014	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—CAV1—glaucoma	1.1e-06	0.000138	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—NOS3—glaucoma	8.28e-07	0.000105	CbGpPWpGaD
Cyclophosphamide—CYP3A4—Metabolism—PTGS2—glaucoma	7.58e-07	9.58e-05	CbGpPWpGaD
